Mortality in Patients with Multiple Sclerosis

Sümeyra Şamlı, Murat Kürtüncü

DOI: 10.4274/tnd.15921

Issue: 2018, Volume 24 - Issue 1
0 271

Fampridine Therapy in Multiple Sclerosis: We Should Think Twice!

Mohamed S A Mohamed

DOI: 10.4274/tnd.65882

Issue: 2018, Volume 24 - Issue 1
0 161

Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis

Burcu Altunrende, Erkingül Birday, Mithat Kasap, Gülşen Akman Demir

DOI: 10.4274/tnd.62144

Issue: 2017, Volume 23 - Issue 4
0 257

Intravenous Thrombolytic Therapy in Acute Ischemic Stroke: The Experience of Kütahya

Mustafa Çetiner, Sibel Canbaz Kabay, Hasan Emre Aydın

DOI: 10.4274/tnd.35651

Issue: 2017, Volume 23 - Issue 4
0 230

Quality of Life, Coping, and Social Support in Patients with Multiple Sclerosis: A Pilot Study

Oğuzhan Zengin, Ercüment Erbay, Buğra Yıldırım, Özgür Altındağ

DOI: 10.4274/tnd.37074

Issue: 2017, Volume 23 - Issue 4
0 296

Flow Cytometry Analysis of Peripheral Blood B Cell Distribution of Patients with Multiple Sclerosis

Vuslat Yılmaz, Deniz Ak Tura, Canan Ulusoy, Duygu Özkan Yaşargün, Suzan Adın Çınar, Recai Türkoğlu

DOI: 10.4274/tnd.87523

Issue: 2017, Volume 23 - Issue 4
0 214

Acute Spinal Pseudoathetosis

Mehmet Fevzi Öztekin, Dilara Mermi Dibek

DOI: 10.4274/tnd.27167

Issue: 2017, Volume 23 - Issue 4
0 174

Weight Loss and Fingolimod

Nefati Kıylıoğlu

DOI: 10.4274/tnd.87528

Issue: 2017, Volume 23 - Issue 4
0 167

The Effect of Ocrelizumab in the Treatment of Multipl Sclerosis

Şenay Yıldız Çelik

DOI: 10.4274/tnd.71354

Issue: 2017, Volume 23 - Issue 3
0 184

Amiselimod: A New Oral Agent in the Treatment of Multiple Sclerosis

Ahmed Serkan Emekli

DOI: 10.4274/tnd.90018

Issue: 2017, Volume 23 - Issue 3
0 158

Evaluation of the Effects of Adipocytokines on Prognosis in Ischemic Cerebrovascular Events

Muzaffer Şükriye Aliye Türkeş Demir, Özge Arıcı Düz, Nihal Işık

DOI: 10.4274/tnd.02170

Issue: 2017, Volume 23 - Issue 2
0 214

The Predictive Role of NEDA in the Long-Term Course of Multiple Sclerosis

Özgü Kizek

DOI: 10.4274/tnd.65391

Issue: 2017, Volume 23 - Issue 1
0 181

Does Serum Vitamin D Level During Pregnancy Influence the Risk of Multiple Sclerosis?

Tuncay Gündüz

DOI: 10.4274/tnd.28566

Issue: 2016, Volume 22 - Issue 4
0 182

Relapses in Multiple Sclerosis: Definition, Pathophysiology, Features, Imitators, and Treatment

Serhan Sevim

DOI: 10.4274/tnd.75318

Issue: 2016, Volume 22 - Issue 3
0 249

Cognitive Impairment in Young Multiple Sclerosis and Essential Tremor Patients: A Comparative Study

Hakan Serdar Şengül, Yıldızhan Şengül, Selma Yücel, Hulki Forta

DOI: 10.4274/tnd.46704

Issue: 2016, Volume 22 - Issue 3
0 236

Investigation of Patients with Hippocampal Sclerosis Associated with Unusual Epileptic Activities

Ebru Nur Vanlı Yavuz, Hakan Yener, Zeynep Aydın Özemir, Nerses Bebek, Candan Gürses, Ayşen Gökyiğit, Betül Baykan

DOI: 10.4274/tnd.80037

Issue: 2016, Volume 22 - Issue 2
0 212

Etiologic Subtypes, Risk Factors And Outcome Of Acute Ischemic Stroke With Young Patients

İnci Şule Özer, Mine Hayriye Sorgun, Sefer Rzayev, Müge Kuzu, Sabiha Tezcan, Volkan Yılmaz, Çağrı Ulukan, Hafize Çotur, Anwar Rawandi, Canan Togay Işıkay

DOI: 10.4274/tnd.68725

Issue: 2015, Volume 21 - Issue 4
0 217

Isolated Complete Horizontal Gaze Palsy and Multiple Sclerosis

Hakan Tekeli, Mustafa Tansel Kendirli, Mehmet Güney Şenol, Rıfat Erdem Toğrol, Mehmet Fatih Özdağ, Serkan Demir

DOI: 10.4274/tnd.93899

Issue: 2015, Volume 21 - Issue 4
0 186

Process From Diagnosis To Treatment Of 3 SSPE Cases Presented At The Late Age

Aylin Bican, İbrahim Bora

DOI: 10.4274/tnd.03789

Issue: 2015, Volume 21 - Issue 3
0 211

A Case Followed as Having Multiple Sclerosis but Diagnosed with Secondary Brain Lymphoma

Serkan Demir, Rıfat Erdem Toğrol, Ali&775; Rıza Sonkaya, Tolga Tuncel

DOI: 10.4274/tnd.70845

Issue: 2015, Volume 21 - Issue 3
0 244